AR092630A1 - Metodos y composiciones para prevenir la incorporacion erronea de norleucina en proteinas - Google Patents
Metodos y composiciones para prevenir la incorporacion erronea de norleucina en proteinasInfo
- Publication number
- AR092630A1 AR092630A1 ARP130103369A ARP130103369A AR092630A1 AR 092630 A1 AR092630 A1 AR 092630A1 AR P130103369 A ARP130103369 A AR P130103369A AR P130103369 A ARP130103369 A AR P130103369A AR 092630 A1 AR092630 A1 AR 092630A1
- Authority
- AR
- Argentina
- Prior art keywords
- norleucine
- methods
- prevent
- compositions
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01046—Homoserine O-succinyltransferase (2.3.1.46)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01006—Methionine adenosyltransferase (2.5.1.6), i.e. adenosylmethionine synthetase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
La presente se refiere a métodos y composiciones para prevenir la incorporación de norleucina en proteínas durante la producción de proteína recombinada en bacterias. Además se provee células huéspedes de microorganismos y moléculas de ácido nucleico para el uso con los métodos y las composiciones que se proveen en la presente solicitud. Reivindicación 1: Un método para la prevención o reducción de la incorporación errónea de norleucina en una proteína o en un polipéptido, donde el método comprende la expresión de la proteína o el polipéptido en un microorganismo, donde el microorganismo es un microorganismo mutante que produce metionina a un grado o alcance suficiente para prevenir o reducir la incorporación errónea de norleucina en la proteína o el polipéptido.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261703142P | 2012-09-19 | 2012-09-19 | |
| US201361777700P | 2013-03-12 | 2013-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR092630A1 true AR092630A1 (es) | 2015-04-29 |
Family
ID=49304344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130103369A AR092630A1 (es) | 2012-09-19 | 2013-09-19 | Metodos y composiciones para prevenir la incorporacion erronea de norleucina en proteinas |
Country Status (21)
| Country | Link |
|---|---|
| US (5) | US20140081003A1 (es) |
| EP (2) | EP3502267A1 (es) |
| JP (3) | JP6479661B2 (es) |
| KR (1) | KR102123134B1 (es) |
| CN (2) | CN104662161A (es) |
| AR (1) | AR092630A1 (es) |
| AU (2) | AU2013318047A1 (es) |
| BR (1) | BR112015005895A2 (es) |
| CA (1) | CA2882463C (es) |
| ES (1) | ES2705493T3 (es) |
| HK (1) | HK1210810A1 (es) |
| HR (1) | HRP20190060T1 (es) |
| IL (2) | IL237310B (es) |
| MX (1) | MX363187B (es) |
| MY (1) | MY180183A (es) |
| PL (1) | PL2898086T3 (es) |
| RU (1) | RU2681928C2 (es) |
| SG (1) | SG11201502076SA (es) |
| SI (1) | SI2898086T1 (es) |
| WO (1) | WO2014047311A1 (es) |
| ZA (1) | ZA201501653B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL262513B (en) * | 2002-09-11 | 2022-09-01 | Genentech Inc | Cleaning proteins |
| US20140081003A1 (en) * | 2012-09-19 | 2014-03-20 | Genentech, Inc. | Methods and compositions for preventing norleucine misincorporation into proteins |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| WO2017117464A1 (en) | 2015-12-30 | 2017-07-06 | Kodiak Sciences Inc. | Antibodies and conjugates thereof |
| EA202091509A1 (ru) * | 2017-12-19 | 2020-09-22 | Акуос, Инк. | Aav-опосредованная доставка терапевтических антител во внутреннее ухо |
| CA3157509A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| WO2024079114A1 (en) * | 2022-10-11 | 2024-04-18 | UCB Biopharma SRL | Process for the production of recombinant proteins |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5599690A (en) | 1988-02-01 | 1997-02-04 | Amgen Inc. | Control of norleucine incorporation into recombinant proteins |
| US5698418A (en) | 1988-02-17 | 1997-12-16 | Pharmacia & Upjohn Company | Fermentation media and methods for controlling norleucine in polypeptides |
| JP2879063B2 (ja) * | 1988-02-17 | 1999-04-05 | ファルマシア・アンド・アップジョン・カンパニー | ポリペプチド類においてノルロイシン含有量を制御するための発酵培地および方法 |
| US7018809B1 (en) | 1991-09-19 | 2006-03-28 | Genentech, Inc. | Expression of functional antibody fragments |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| DE122005000026I1 (de) | 1997-04-07 | 2005-08-04 | Genentech Inc | Anti-VEGF Antik¦rper. |
| JP4110641B2 (ja) * | 1998-11-17 | 2008-07-02 | 味の素株式会社 | 発酵法によるｌ−メチオニンの製造法 |
| ES2324645T3 (es) | 2000-11-03 | 2009-08-12 | Genentech, Inc. | Cambios de tasa metabolica en fermentaciones que expresen proteinas recombinantes. |
| DE10247437A1 (de) | 2002-10-11 | 2004-04-29 | Consortium für elektrochemische Industrie GmbH | Feedback-resistente Homoserin-Transsuccinylasen |
| DE10249642A1 (de) | 2002-10-24 | 2004-05-13 | Consortium für elektrochemische Industrie GmbH | Feedback-resistente Homoserin-Transsuccinylasen mit modifiziertem C-Terminus |
| DE10305774A1 (de) | 2003-02-06 | 2004-08-26 | Consortium für elektrochemische Industrie GmbH | Verfahren zur fermentativen Herstellung von L-Methionin |
| ATE448321T1 (de) | 2003-09-25 | 2009-11-15 | Monsanto Technology Llc | Verhinderung des einbaus von nichtstandard- aminosäuren in protein |
| WO2005111202A1 (en) * | 2004-05-12 | 2005-11-24 | Metabolic Explorer | Recombinant enzyme with altered feedback sensitivity |
| WO2007103521A2 (en) * | 2006-03-07 | 2007-09-13 | Novartis Ag | Preventing norvaline and norleucine misincorporation in recombinant proteins |
| EP2471818A1 (en) | 2006-11-02 | 2012-07-04 | Genentech, Inc. | Humanized anti-factor D antibodies and uses thereof |
| CR20170001A (es) | 2008-04-28 | 2017-08-10 | Genentech Inc | Anticuerpos anti factor d humanizados |
| MX346002B (es) * | 2009-06-17 | 2017-03-01 | Abbvie Biotherapeutics Inc | Anticuerpos anti-vegf y sus usos. |
| JP5817529B2 (ja) * | 2009-11-30 | 2015-11-18 | 味の素株式会社 | Ｌ−システイン生産菌及びｌ−システインの製造法 |
| US20110287003A1 (en) * | 2010-05-14 | 2011-11-24 | Genentech, Inc. | Treatment methods |
| US20140081003A1 (en) * | 2012-09-19 | 2014-03-20 | Genentech, Inc. | Methods and compositions for preventing norleucine misincorporation into proteins |
-
2013
- 2013-09-19 US US14/031,463 patent/US20140081003A1/en not_active Abandoned
- 2013-09-19 CN CN201380048535.XA patent/CN104662161A/zh active Pending
- 2013-09-19 CN CN202011466081.6A patent/CN112575018A/zh active Pending
- 2013-09-19 RU RU2015111350A patent/RU2681928C2/ru active
- 2013-09-19 SG SG11201502076SA patent/SG11201502076SA/en unknown
- 2013-09-19 ES ES13773482T patent/ES2705493T3/es active Active
- 2013-09-19 MY MYPI2015000662A patent/MY180183A/en unknown
- 2013-09-19 BR BR112015005895A patent/BR112015005895A2/pt not_active Application Discontinuation
- 2013-09-19 JP JP2015532180A patent/JP6479661B2/ja active Active
- 2013-09-19 MX MX2015003281A patent/MX363187B/es unknown
- 2013-09-19 PL PL13773482T patent/PL2898086T3/pl unknown
- 2013-09-19 KR KR1020157009711A patent/KR102123134B1/ko active IP Right Grant
- 2013-09-19 AR ARP130103369A patent/AR092630A1/es not_active Application Discontinuation
- 2013-09-19 WO PCT/US2013/060653 patent/WO2014047311A1/en active Application Filing
- 2013-09-19 SI SI201331317T patent/SI2898086T1/sl unknown
- 2013-09-19 AU AU2013318047A patent/AU2013318047A1/en not_active Abandoned
- 2013-09-19 EP EP18194260.8A patent/EP3502267A1/en active Pending
- 2013-09-19 CA CA2882463A patent/CA2882463C/en active Active
- 2013-09-19 EP EP13773482.8A patent/EP2898086B1/en active Active
-
2015
- 2015-02-19 IL IL237310A patent/IL237310B/en active IP Right Grant
- 2015-03-11 ZA ZA2015/01653A patent/ZA201501653B/en unknown
- 2015-11-25 HK HK15111589.7A patent/HK1210810A1/xx unknown
-
2016
- 2016-03-11 US US15/067,646 patent/US9850514B2/en active Active
-
2017
- 2017-05-08 AU AU2017203049A patent/AU2017203049B2/en active Active
- 2017-11-17 US US15/816,305 patent/US10179925B2/en active Active
-
2018
- 2018-04-12 US US15/951,895 patent/US10421984B2/en active Active
- 2018-11-29 JP JP2018223132A patent/JP6796631B2/ja active Active
-
2019
- 2019-01-09 HR HRP20190060TT patent/HRP20190060T1/hr unknown
- 2019-08-08 US US16/536,149 patent/US11015214B2/en active Active
-
2020
- 2020-02-23 IL IL272866A patent/IL272866B/en active IP Right Grant
- 2020-11-16 JP JP2020190225A patent/JP2021048849A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR092630A1 (es) | Metodos y composiciones para prevenir la incorporacion erronea de norleucina en proteinas | |
| CL2016001553A1 (es) | Medios para cultivo celular | |
| MX352823B (es) | Formulaciones de proteinas que contienen aminoacidos. | |
| EA201890137A1 (ru) | Среда для культивирования клеток с добавлением таурина и способы применения | |
| GB2569733A (en) | RNA-guided nucleic acid modifying enzymes and methods of use thereof | |
| MX2021010518A (es) | Medios y metodos de fermentacion para producir polisacarido en cultivo celular bacteriano. | |
| CO6440530A2 (es) | Formulaciones de caldo de fermentación | |
| EA201270151A1 (ru) | Способы и композиции для рекомбинантного биосинтеза h-алканов | |
| BR112015006426A2 (pt) | composições nutricionais que incluem beta-hidróxi-beta-metilbutirato de cálcio, proteína e baixos níveis de eletrólitos | |
| AR084377A1 (es) | Metodos y composiciones relacionados con enzimas de alcohol graso biosintetico | |
| PH12016502148A1 (en) | Methods of microalgae cultivation for increased resource production | |
| BR112015013525A2 (pt) | método para produção de uma proteína de fusão, bem como composição compreendendo uma proteína de fusão | |
| BR112013020767A2 (pt) | composições compreendendo ácido peróxi alfa-cetocarboxílico e métodos para a produção e o uso do mesmo | |
| EA201591817A1 (ru) | Не содержащая сыворотки среда для культивирования клеток | |
| BR112015020904A2 (pt) | microrganismos e métodos para produção de butadieno e compostos relacionados por assimilação de formiato | |
| BR112016016524A2 (pt) | célula de levedura transformada | |
| BR112016006048A8 (pt) | composições antimicrobianas | |
| BR112016004510A2 (pt) | composições bioativas deriváveis de concentrados de plaquetas e métodos para preparar e usar as mesmas | |
| AR068419A1 (es) | Cepas de mycoplasma atenuadas vivas | |
| EA201490945A1 (ru) | Набор, содержащий заменитель сыворотки и лабильные факторы | |
| BR112014002173A2 (pt) | proteínas purificadas | |
| BR112014000542A2 (pt) | composições de peroxidase eosinofílica e métodos de uso das mesmas | |
| BR112017003556A2 (pt) | método de cultivo de um micro-organismo. | |
| EA201891335A1 (ru) | Добавление аргинина с целью повышения эффективности ацетогенов, ферментирующих газ | |
| WO2018183848A8 (en) | Media for microorganism culture and related compositions and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |